Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 266

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 266
---
  73,982 |     |   |  68,779 |
| Other payables                            |     |                 |  26,432 |     |   |  26,170 |
| Total accrued expenses and other payables |     | $               | 447,652 |     | $ | 437,420 |

Note 9 – Shareholders’ equity

The Company is established under the laws of the
Cayman Islands on May 7, 2024 with 50,000 authorized ordinary shares with a par value of $1.

On August 28, 2024, a shareholder resolution was
passed and approved and the article of association of the Company was amended that (i) the number of authorized shares increased from
50,000 shares to 500,000,000 shares and divided into 450,000,000 Class A Ordinary Shares and 50,000,000 Class B Ordinary Shares; and (ii)
the par value of the shares decreased from $1 each to $0.0001 each (collectively refer as the “Share Re-classification”).
The authorized share capital of the Company remained unchanged at $50,000. The 1 issued ordinary share held by LTO was reclassified as
10,000 Class A Ordinary Shares upon the Share Re-classification. The Company further allotted and issued 8,990,000 Class A Ordinary Shares
at $899 and 1,000,000 Class B Ordinary Shares at $100, respectively to LTO. On September 10, 2024, certain strategic investors acquired
4,320,000 Class A Ordinary Shares and 480,000 Class B Ordinary Shares, respectively.

Holders of Class A Ordinary Shares and Class B
Ordinary Shares shall vote together as a single class on all resolutions of the shareholders and have the same rights except each Class
A Ordinary Share shall entitle its holder to one (1) vote and each Class B Ordinary Share shall entitle its holder to fifteen (15) votes.
Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof but Class
A Ordinary Shares are not convertible into Class B Ordinary Shares.

The Company considered the above transactions
as a part of the Company’s recapitalization prior to completion of its initial public offering, the Company has retroactively restated
all shares and per share data for all the periods presented.

The Company declared cash dividends of $325,078